Cipta Sarana Medika Tbk. vs Japfa Comfeed Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Japfa Comfeed Indonesia Tbk. trades at Rp2,030 (market cap 23.69T, 13.03M 24h volume). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 149.8× Cipta Sarana Medika Tbk.'s market cap, and Japfa Comfeed Indonesia Tbk. is more actively traded (13.03M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | JPFA | |
|---|---|---|
Market Cap | 158.12B | 23.69T |
Volume | 8.21M | 13.03M |
Lot | 82.15K | 130.26K |
Turnover | 515.2M | 26.31B |
Average Price | 62.72 | 2,019.74 |
Value | 515.2M | 26.31B |
Indicative Equilibrium Price | 63 | 2,030 |
Indicative Equilibrium Volume | 1.33K | 8.34K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Read more on JPFA →